James Welsh, MD

MD Anderson Cancer Center

Disclosure:
Ownership
Healios: Stock; MolecularMatch: Stock; OncoResponse: Stock Options; Reflexion Medical: Stock Options

Biography:
James W. Welsh, MD, is a Tenured Physician Scientist at The University of Texas MD Anderson Cancer Center. At MD Anderson he is the director of the immune radiation program, with the goal of using radiation to turn the tumor into an “in-situ” vaccine to prime T cells, turning radiation into a systemic therapy. Being able to both see patients and run a lab has provided insights on how to improve patient care. His lab recently developed the first mouse model of PD1 resistance and they actively investigate the mechanisms how cancer cells adapt to evade the immune system.

Presentation(s):

• 33 - Phase I Trial of MK-3475 and Concurrent Radiation for the Elimination of Extensive-Stage Small Cell Lung Cancer

  Sunday, October 21
  5:25 PM – 5:35 PM

• TU_38_3702 - Phase I Trial of MK-3475 and Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer

  Tuesday, October 23
  2:45 PM – 4:15 PM